Twist Bioscience Corporation

TWST | Healthcare | NASDAQ
$46.48
+3.22 (+7.43%)

Key Metrics

Market Cap
$2.85B
P/E Ratio
-36.59
EPS
$-1.27
Beta
N/A
Dividend Yield
N/A
ROE
-16.82%
Current Ratio
3.64

Company Information

Industry
Medical Diagnostics Research

About Twist Bioscience Corporation

Twist Bioscience Corporation a synthetic biology company manufactures and sells synthetic DNAbased products The companys DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip It offers synthetic DNAbased products including synthetic genes tools for sample preparation antibody libraries for drug discovery and development and DNA as a digital data storage medium The company has collaboration agreements with Victorian Clinical Genetic Services Vivlion GmbH Kyowa Kirin Pharmaceutical Research Inc deepCDR Biologics AG and Centogene NV to develop advanced sequencing tools It also has a research collaboration with Boehringer Ingelheim International GmbH to use proprietary antibody libraries to discover therapeutic antibodies against multiple targets Twist Bioscience Corporation was incorporated in 2013 and is headquartered in South San Francisco California

Recent Earnings Surprises

Date Actual EPS Estimated EPS Surprise
2026-02-02 $-0.50 $-0.48 4.2%
2025-11-14 $-0.45 $-0.50 +-10.0%
2025-08-04 $-0.47 $-0.54 +-13.0%
2025-05-05 $-0.66 $-0.56 17.9%

Financial Ratios (TTM)

Gross Margin
50.72%
Operating Margin
-36.18%
Net Margin
-20.63%
ROA
-12.10%
Price to Book
5.25
Price to Sales
6.68